J0751 HCPCS Level II code: Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of…
J0751 is the HCPCS code for “Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
Short description: Hiv prep, ftc/taf 200/25mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0751 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Other carrier priced
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Coverage statute
- 1861(ddd)
- Added
- Jan 2, 2024
Where J0751 sits
- 1J codesDrugs administered other than orally
- 2Active code J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0751 mean?
J0751 is the HCPCS code for “Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0751?
CMS lists J0751’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0751
All J codesJ0741Injection, cabotegravir and rilpivirine, 2mg/3mgJ0742Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mgJ0743Injection, cilastatin sodium; imipenem, per 250 mgJ0744Injection, ciprofloxacin for intravenous infusion, 200 mgJ0745Injection, codeine phosphate, per 30 mgJ0750Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)J0759Injection, clevidipine butyrate, 1 mgJ0760Injection, colchicine, per 1 mgJ0770Injection, colistimethate sodium, up to 150 mgJ0775Injection, collagenase, clostridium histolyticum, 0.01 mgJ0780Injection, prochlorperazine, up to 10 mg